(Q37104744)

18 August 2017

1 reference

title

Human cytomegalovirus infection and antiviral immunity in septic patients without canonical immunosuppression (English)

1 reference

18 August 2017

0 references

0 references

1 reference

cytomegaloviral disease

1 reference

Lutz von Müller

1

0 references

author name string

Thomas Mertens

series ordinal

2

1 reference

18 August 2017

8 March 2008

1 reference

Medical Microbiology and Immunology

18 August 2017

1 reference

18 August 2017

197

1 reference

18 August 2017

2

1 reference

18 August 2017

75-82

1 reference

https://scigraph.springernature.com/pub.10.1007/s00430-008-0087-0

18 August 2017

0 references

cites work

Active cytomegalovirus infection in patients with septic shock

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00430-008-0087-0

Human cytomegalovirus strain-dependent changes in NK cell recognition of infected fibroblasts.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00430-008-0087-0

Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group.

21 January 2018

1 reference

12 December 2020

Blastogenic response of human lymphocytes to human cytomegalovirus

1 reference

12 December 2020

Preemptive CD8 T-cell immunotherapy of acute cytomegalovirus infection prevents lethal disease, limits the burden of latent viral genomes, and reduces the risk of virus recurrence

1 reference

12 December 2020

Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors

1 reference

12 December 2020

Lipopolysaccharide, tumor necrosis factor alpha, or interleukin-1beta triggers reactivation of latent cytomegalovirus in immunocompetent mice

1 reference

12 December 2020

Quantitation of cytomegalovirus: methodologic aspects and clinical applications.

1 reference

12 December 2020

CD8 T cells control cytomegalovirus latency by epitope-specific sensing of transcriptional reactivation

1 reference

12 December 2020

In vivo/ex vivo T cell depletion for GVHD prophylaxis influences onset and course of active cytomegalovirus infection and disease after BMT

1 reference

12 December 2020

Adoptive immunotherapy of murine cytomegalovirus adrenalitis in the immunocompromised host: CD4-helper-independent antiviral function of CD8-positive memory T lymphocytes derived from latently infected donors.

1 reference

12 December 2020

Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation

1 reference

12 December 2020

Definitions of cytomegalovirus infection and disease in transplant recipients

1 reference

12 December 2020

Rapid generation of combined CMV-specific CD4+ and CD8+ T-cell lines for adoptive transfer into recipients of allogeneic stem cell transplants

1 reference

12 December 2020

Superantigens: microbial agents that corrupt immunity

1 reference

12 December 2020

Immunomodulation by cytomegaloviruses: manipulative strategies beyond evasion

1 reference

12 December 2020

Passive Immunization during Pregnancy for Congenital Cytomegalovirus Infection

1 reference

12 December 2020

Cytomegalovirus reactivation and tumour necrosis factor

1 reference

12 December 2020

Dendritic cell function in cytomegalovirus-infected patients with mononucleosis

1 reference

12 December 2020

A model for reactivation of CMV from latency

1 reference

12 December 2020

Severe graft rejection, increased immunosuppression, and active CMV infection in renal transplantation

1 reference

12 December 2020

Allogeneic transplantation induces expression of cytomegalovirus immediate-early genes in vivo: a model for reactivation from latency

1 reference

12 December 2020

Is the cytomegalovirus serologic status always accurate? A comparative analysis of humoral and cellular immunity1

1 reference

12 December 2020

Human cytomegalovirus infections in nonimmunosuppressed critically ill patients

1 reference

12 December 2020

Practices for cytomegalovirus diagnosis, prophylaxis and treatment in allogeneic bone marrow transplant recipients: a report from the Working Party for Infectious Diseases of the EBMT.

1 reference

12 December 2020

In vitro studies of natural killer cell activity in septic shock patients. Response to a challenge with alpha-interferon and interleukin-2

1 reference

12 December 2020

Cytopathology or immunopathology? The puzzle of cytomegalovirus pneumonitis revisited

1 reference

12 December 2020

Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones

1 reference

12 December 2020

Protection from CMV infection in immunodeficient hosts by adoptive transfer of memory B cells

1 reference

12 December 2020

Intra-abdominal bacterial infection reactivates latent pulmonary cytomegalovirus in immunocompetent mice

1 reference

12 December 2020

Latency and reactivation of human cytomegalovirus

1 reference

12 December 2020

CMV monitoring using blood cells and plasma: a comparison of apples with oranges?

1 reference

12 December 2020

Cytomegalovirus infection in burns: a review

1 reference

12 December 2020

The conditions of primary infection define the load of latent viral genome in organs and the risk of recurrent cytomegalovirus disease.

1 reference

12 December 2020

Cytomegalovirus in transplantation - challenging the status quo.

1 reference

12 December 2020

Cellular Immunity and Active Human Cytomegalovirus Infection in Patients with Septic Shock

1 reference

12 December 2020

Vascular endothelial and smooth muscle cells are unlikely to be major sites of latency of human cytomegalovirus in vivo.

1 reference

12 December 2020

Interleukin-6 (IL-6) expression and natural killer (NK) cell dysfunction and anergy in heart failure

1 reference

12 December 2020

High incidence of active cytomegalovirus infection among septic patients

1 reference

12 December 2020

Immune escape and exploitation strategies of cytomegaloviruses: impact on and imitation of the major histocompatibility system

1 reference

12 December 2020

Tomorrow's challenges for herpesvirus management: potential applications of valacyclovir

1 reference

12 December 2020

Management of CMV infections: recommendations from the infectious diseases working party of the EBMT.

1 reference

12 December 2020

Infection in solid-organ transplant recipients

1 reference

12 December 2020

Pulmonary cytomegalovirus reactivation causes pathology in immunocompetent mice

1 reference

12 December 2020

Levels of virus-specific CD4 T cells correlate with cytomegalovirus control and predict virus-induced disease after renal transplantation

1 reference

12 December 2020

Quantitative analysis of latent human cytomegalovirus

1 reference

12 December 2020

Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy

1 reference

12 December 2020

Natural killer cells and viral infections

1 reference

12 December 2020

Latency, chromatin remodeling, and reactivation of human cytomegalovirus in the dendritic cells of healthy carriers

1 reference

12 December 2020

Role for tumor necrosis factor alpha in murine cytomegalovirus transcriptional reactivation in latently infected lungs

1 reference

12 December 2020

Clonal repertoire diversification of a neutralizing cytomegalovirus glycoprotein B-specific antibody results in variants with diverse anti-viral properties

1 reference

12 December 2020

10.1007/S00430-008-0087-0

Identifiers

DOI

1 reference

release_fn5vjxnl3nganomokxkl2w52b4

18 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/fn5vjxnl3nganomokxkl2w52b4

24 November 2022

mapped directly with Wikidata item

PubMed ID

18327609

1 reference

PubMed ID

18327609